(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Corporate Development John Richard, all purchased shares in the biopharmaceutical company.
In a transaction on Friday, Sermon acquired 6355 shares at a price of 54 pence each, worth GBP3,432, while Richard purchased 1,500 American depository shares at USD3.31, for a total of USD4,965.
On the same day, Scots-Knight bought 6,000 shares at the same price, totalling GBP3,240. This was followed by a transaction on Friday, when Scots-Knight purchased a further 6,000 shares at 54p each.
Mereo BioPharma shares were trading 6.7% higher in London on Friday at 55.50p each.